Thabor Therapeutics

Thabor Therapeutics is a biotechnology company focused on treating human mucosal inflammatory diseases by inhibiting novel targets potentially implicated in early inflammatory processes and the recruitment of innate immune cells. The company aims to develop first-in-class drugs specifically targeting new proteins involved in the resolution of inflammation.